6505--RX - Brand name or Equal to Pylarify
Veterans Affairs · 242-NETWORK CONTRACT OFFICE 02 (36C242)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24226Q0246 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
This is a pre-solicitation notice-The official solicitation will be posted 03/05/2026 at 10AM
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same office (242-NETWORK CONTRACT OFFICE 02 (36C242)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (7): middle half $475K to $1.9M, median $959K; range $305K to $4.2M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SOFIE Co. DULLES 20166 | 2 | $6.1M | Mar 5, 2026 |
| OPTUM INFUSION SERVICES 308, LLC | 1 | $1.9M | Oct 1, 2026 |
| NUCLEAR DIAGNOSTIC PRODUCTS, INC | 1 | $959K | Feb 24, 2026 |
| OPTUM PHARMACY 801, INC. | 1 | $567K | May 5, 2025 |
| PETNET SOLUTIONS, INC. | 1 | $382K | Jun 25, 2025 |
| CARDINAL HEALTH 414, LLC · $CAH · $226.8B | 1 | $305K | Jul 6, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $226.8B revenue in FY2026. The median single-winner award in these 7 past awards, $959K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026OPTUM INFUSION SERVICES 308, LLC$1.9M6505--Chemo Compounding - East OrangeNo listed company matched (Materiality N/A)
- Jul 6, 2026CARDINAL HEALTH 414, LLC$305K6505--Nuclear Medicine Radiopharmaceuticals (VA-26-00043023) WNY VAMCMateriality: <0.01% of $CAH revenue (Low) SEC
- Mar 5, 2026SOFIE Co. DULLES 20166$4.2M6505--PET Radiopharmaceuticals for the Albany VA Medical CenterNo listed company matched (Materiality N/A)
- Feb 24, 2026NUCLEAR DIAGNOSTIC PRODUCTS, INC$959K6505--GENERAL RADIOPHARMACEUTICALSNo listed company matched (Materiality N/A)
- Jun 25, 2025PETNET SOLUTIONS, INC.$382KRX - AMYVID (F-18 FLORBETAPIR INJECTION - NDC 00002-1200-01)No listed company matched (Materiality N/A)
- May 5, 2025OPTUM PHARMACY 801, INC.$567K6505--Chemo Compounding NJHCS East Orange, NJ CampusNo listed company matched (Materiality N/A)
- Apr 14, 2025SOFIE Co. DULLES 20166$1.9M6505--PET Radiopharmaceuticals for Buffalo VA Medical CenterNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.